Edition:
United Kingdom

Health News Headlines

Germany's Merck in fresh bid to enter U.S. MS pill market

Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the U.S. market, hoping for blockbuster sales despite regulatory concerns about side effects having frustrated its ambitions almost seven years ago.